drugset / Trial / NCT00333450

Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.

NCT00333450 ↗

Phase 3 Completed 120 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate the immunological memory against pneumococcal vaccine serotypes in children primed with conjugate vaccines by administering a booster dose of plain polysaccharide vaccine.

Timeline

Start
2006-08
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK Biologicals' Pneumococcal Conjugate Vaccine Vaccine — —
Subject Pneumovax 23 Vaccine — —
Subject Prevenar Vaccine — —